Kiromic Biopharma Valuation

Kiromic Biopharma Asset Utilization

One of the ways to look at asset utilization of Kiromic is to check how much profit was generated for every dollar of assets it reports. Kiromic Biopharma secures a negative usage of assets of -0.92 %, losing $0.009194 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Kiromic Biopharma shows how discouraging it operates for each dollar spent on its assets.

Kiromic Biopharma Ownership Allocation

Over half of Kiromic Biopharma's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions.

Kiromic Biopharma Profitability Analysis

Net Loss for the year was (34.73 M) with profit before overhead, payroll, taxes, and interest of 0.

Investing in growth stocks can be very risky. If the company such as Kiromic Biopharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.